Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Academic Appointments
Last Updated 10/19/2023
Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank:
Associate Professor
Years:
2004-Present
Johns Hopkins University School Of Medicine - Baltimore MD
Rank:
Assistant Professor
Years:
2007-2011
Pennsylvania State University College Of Medicine - Hershey PA
Rank:
Clinical Associate Professor of Surgery
Years:
2021-2023
Publications
(up to ten in the last five years)
Last Updated 10/19/2023
Analysis of CD4 and CD8 T cell Populations Induced by a HER2/neu Peptide (E75) Vaccine in Breast Cancer Patients
Cancer Immunol Immunother
2007 Feb;56(2):135-46
Date: 02 2007
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Clin Cancer Res
2008 Feb 1;14(3):797-803
Date: 02 2008
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Cancer
. 2008 Aug 25; 113(7):1666-1675
Date: 08 2008
Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial
J Am Coll Surg
2010 Feb;210(2):140-7
Date: 02 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide
Vaccine
2010 Nov 3;28(47):7476-82
Date: 11 2010
Creating prognostic systems for cancer patients: A demonstration using breast cancer
Cancer Med
2018 Aug;7(8):3611- 3621.
Date: 08 2018
Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population
Mil Med
2017 Nov;182(11):e1851-e1858
Date: 11 2018
Serum Biomarkers for Racial Disparities in Breast Cancer Progression
Mil Med
2019 Mar 1;184(Supplement_1):652-657
Date: 03 2019
Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital
Ann Surg Oncol
2019 Nov; 26(12): 3838-3845.
Date: 11 2019
Proteomic Analysis of Inflammatory Biomarkers Associated with Breast Cancer Recurrence.
Military Medicine
Mil Med. 2020 Jan 7;185(Supplement_1):669-675
Date: 01 2020